WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Inc Stock

$8.36-0.30 (-3.46%)
Updated Jul 17, 2024
FULC Price
$8.36
Fair Value Price
$0.04
Market Cap
$519.60M
52 Week Low
$3.14
52 Week High
$13.70
P/E
-5.23x
P/B
2.43x
P/S
233.12x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.51M
Earnings
-$99.43M
Gross Margin
100%
Operating Margin
-3,961.2%
Profit Margin
-3,961.2%
Debt to Equity
0.09
Operating Cash Flow
-$92M
Beta
1.54
Next Earnings
Aug 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A

FULC Overview

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FULC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FULC ($8.36) is overvalued by 22,037.48% relative to our estimate of its Fair Value price of $0.04 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
FULC ($8.36) is not significantly undervalued (22,037.48%) relative to our estimate of its Fair Value price of $0.04 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FULC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FULC due diligence checks available for Premium users.

Be the first to know about important FULC news, forecast changes, insider trades & much more!

FULC News

Valuation

FULC fair value

Fair Value of FULC stock based on Discounted Cash Flow (DCF)
Price
$8.36
Fair Value
$0.04
Overvalued by
22,037.48%
FULC ($8.36) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FULC ($8.36) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FULC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

FULC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-5.23x
Industry
-21.17x
Market
30.24x

FULC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.43x
Industry
6.35x
FULC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

FULC's financial health

Profit margin

Revenue
$0.0
Net Income
-$26.9M
Profit Margin
0%
FULC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
FULC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$232.6M
Liabilities
$19.0M
Debt to equity
0.09
FULC's short-term assets ($217.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FULC's short-term assets ($217.95M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FULC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$25.3M
Investing
$38.1M
Financing
$1.7M
FULC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

FULC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
FULC$519.60M-3.46%-5.23x2.43x
LXRX$524.48M-4.48%-2.57x1.82x
HRTX$527.29M-4.63%-5.93x-15.62x
THRD$511.87M-3.70%-16.67x1.94x
ALT$531.06M-7.53%-4.65x3.07x

Fulcrum Therapeutics Stock FAQ

What is Fulcrum Therapeutics's quote symbol?

(NASDAQ: FULC) Fulcrum Therapeutics trades on the NASDAQ under the ticker symbol FULC. Fulcrum Therapeutics stock quotes can also be displayed as NASDAQ: FULC.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.

What is the 52 week high and low for Fulcrum Therapeutics (NASDAQ: FULC)?

(NASDAQ: FULC) Fulcrum Therapeutics's 52-week high was $13.70, and its 52-week low was $3.14. It is currently -38.98% from its 52-week high and 166.24% from its 52-week low.

How much is Fulcrum Therapeutics stock worth today?

(NASDAQ: FULC) Fulcrum Therapeutics currently has 62,153,638 outstanding shares. With Fulcrum Therapeutics stock trading at $8.36 per share, the total value of Fulcrum Therapeutics stock (market capitalization) is $519.60M.

Fulcrum Therapeutics stock was originally listed at a price of $13.50 in Jul 18, 2019. If you had invested in Fulcrum Therapeutics stock at $13.50, your return over the last 4 years would have been -38.07%, for an annualized return of -11.29% (not including any dividends or dividend reinvestments).

How much is Fulcrum Therapeutics's stock price per share?

(NASDAQ: FULC) Fulcrum Therapeutics stock price per share is $8.36 today (as of Jul 17, 2024).

What is Fulcrum Therapeutics's Market Cap?

(NASDAQ: FULC) Fulcrum Therapeutics's market cap is $519.60M, as of Jul 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Fulcrum Therapeutics's market cap is calculated by multiplying FULC's current stock price of $8.36 by FULC's total outstanding shares of 62,153,638.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.